British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults
![Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat | BMJ Open Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/11/6/e044712/F1.large.jpg)
Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat | BMJ Open
![Identifying and Managing Iron Deficiency and Iron Deficiency Anaemia | Agency for Clinical Innovation Identifying and Managing Iron Deficiency and Iron Deficiency Anaemia | Agency for Clinical Innovation](https://aci.health.nsw.gov.au/__data/assets/image/0006/376287/iron-deficiency-web.png)
Identifying and Managing Iron Deficiency and Iron Deficiency Anaemia | Agency for Clinical Innovation
![Table 1 from Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice. Table 1 from Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.](https://d3i71xaburhd42.cloudfront.net/043b2a5ba28a40e47902d8e39c10bafc324dabd6/2-Table1-1.png)
Table 1 from Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
![JCM | Free Full-Text | Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How? JCM | Free Full-Text | Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?](https://www.mdpi.com/jcm/jcm-11-02976/article_deploy/html/images/jcm-11-02976-g003.png)
JCM | Free Full-Text | Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
![JCM | Free Full-Text | Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How? JCM | Free Full-Text | Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?](https://www.mdpi.com/jcm/jcm-11-02976/article_deploy/html/images/jcm-11-02976-g001.png)
JCM | Free Full-Text | Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
![Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial - Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial -](https://www.thelancet.com/cms/asset/c7df5a2a-8630-4a1e-87a6-4ea7ac28a2fa/gr1.jpg)
Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial -
![Anemia warrants treatment to improve survival in patients with heart failure receiving sacubitril–valsartan | Scientific Reports Anemia warrants treatment to improve survival in patients with heart failure receiving sacubitril–valsartan | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-11886-2/MediaObjects/41598_2022_11886_Fig1_HTML.png)
Anemia warrants treatment to improve survival in patients with heart failure receiving sacubitril–valsartan | Scientific Reports
![Abstract 13788: Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure | Circulation Abstract 13788: Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure | Circulation](https://www.ahajournals.org/cms/asset/532de952-ab6c-4294-aa12-a041adf04ef4/g13788.jpg)
Abstract 13788: Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure | Circulation
![Iron deficiency in sepsis patients managed with divided doses of iron dextran: a prospective cohort study | Scientific Reports Iron deficiency in sepsis patients managed with divided doses of iron dextran: a prospective cohort study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-023-32002-y/MediaObjects/41598_2023_32002_Fig1_HTML.png)